Related Experiment Video
Updated: Aug 17, 2026

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
Published on: June 14, 2016
Dexamethasone suppresses mucus production and MUC-2 and MUC-5AC gene expression by NCI-H292 cells
H Kai1, K Yoshitake, A Hisatsune
1Department of Pharmacological Sciences, Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.
Abstract:
Excessive production of airway mucus is a characteristic feature of many chronic inflammatory lung diseases. Although current pharmacological approaches to excessive mucus production are limited, glucocorticoids appear to be the most effective among a few useful drugs. The exact evidence for the effectiveness of glucocorticoids on mucus production has not been fully elucidated to date. The purpose of this study is to clarify the effect of dexamethasone on mucus production and mucin gene expression in a human pulmonary mucoepidermoid carcinoma cell line (NCI-H292). NCI-H292 cells produced hyaluronidase-resistant high-molecular-weight glycoconjugates (HMWG), which elute in the void volume on Sepharose CL-4B column chromatography. Dexamethasone significantly suppressed the basal production of [3H]glucosamine-or [3H]serine-labeled HMWG in NCI-H292 cells. In Northern blot analysis, dexamethasone attenuated steady-state mRNA levels of MUC-2 and MUC-5AC mucin genes. These data indicate that dexamethasone suppresses the basal production of HMWG and decreases steady-state mRNA levels of mucin genes in airway mucus-producing cancer cells.
Insights
Dexamethasone effectively reduces mucus production and lowers mucin gene expression in airway cells. This study clarifies glucocorticoid effectiveness in managing excessive mucus in lung diseases.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Pharmacology
Background:
- Excessive airway mucus is a hallmark of chronic lung diseases.
- Glucocorticoids are the most effective drugs for mucus overproduction, but their precise mechanisms are unclear.
- Understanding mucus regulation is crucial for treating inflammatory lung conditions.
Purpose of the Study:
- To investigate the impact of dexamethasone on mucus production.
- To examine dexamethasone's effect on mucin gene expression.
- To elucidate the role of glucocorticoids in airway mucus regulation.
Main Methods:
- Utilized a human pulmonary mucoepidermoid carcinoma cell line (NCI-H292).
- Assessed mucus production using [3H]glucosamine and [3H]serine-labeled high-molecular-weight glycoconjugates (HMWG).
- Analyzed mucin gene expression (MUC-2, MUC-5AC) via Northern blot.
Main Results:
- Dexamethasone significantly inhibited basal production of HMWG in NCI-H292 cells.
- Dexamethasone treatment led to decreased steady-state mRNA levels of MUC-2 and MUC-5AC mucin genes.
- The study confirmed dexamethasone's suppressive effect on mucus production and mucin gene expression.
Conclusions:
- Dexamethasone suppresses basal high-molecular-weight glycoconjugate production.
- Dexamethasone reduces mucin gene expression in airway mucus-producing cancer cells.
- These findings support dexamethasone's therapeutic potential in managing excessive airway mucus.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...

